# Filing Detail

Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0001493152-26-019473
Filing Date
2026-04-29
Accepted
2026-04-29 08:00:29
Documents
17
Period of Report
2026-04-29

Document Format Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
1 | DEF 14A | formdef14a.htm iXBRL | DEF 14A | 610390
2 | GRAPHIC | formdef14a_001.jpg | GRAPHIC | 17421
3 | GRAPHIC | proxy_001.jpg | GRAPHIC | 331195
4 | GRAPHIC | proxy_002.jpg | GRAPHIC | 341414
| Complete submission text file | 0001493152-26-019473.txt |  | 2726114

Data Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
5 | XBRL SCHEMA FILE | gnlx-20251231.xsd | EX-101.SCH | 3413
6 | XBRL DEFINITION FILE | gnlx-20251231_def.xml | EX-101.DEF | 3363
7 | XBRL LABEL FILE | gnlx-20251231_lab.xml | EX-101.LAB | 53108
8 | XBRL PRESENTATION FILE | gnlx-20251231_pre.xml | EX-101.PRE | 41976
20 | EXTRACTED XBRL INSTANCE DOCUMENT | formdef14a_htm.xml | XML | 2781

Mailing Address 2625 TOWNSGATE ROAD, SUITE 230 WESTLAKE VILLAGE CA 91361
Business Address 2625 TOWNSGATE ROAD, SUITE 230 WESTLAKE VILLAGE CA 91361 805-267-9889
GENELUX Corp (Filer) CIK: 0001231457 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEF 14A | Act: 34 | File No.: 001-41599 | Film No.: 26910613
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)